Basilea Pharmaceutica AG (OTCMKTS:BPMUF - Get Free Report)'s stock price reached a new 52-week high during trading on Wednesday . The company traded as high as $67.75 and last traded at $67.75, with a volume of 15 shares traded. The stock had previously closed at $61.34.
Basilea Pharmaceutica Price Performance
The stock has a fifty day simple moving average of $58.00 and a 200-day simple moving average of $53.80. The company has a debt-to-equity ratio of 1.18, a quick ratio of 4.16 and a current ratio of 4.85.
About Basilea Pharmaceutica
(
Get Free Report)
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.
Featured Articles
Before you consider Basilea Pharmaceutica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Basilea Pharmaceutica wasn't on the list.
While Basilea Pharmaceutica currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access